Neuzumab 440 is a cancer medicine that contains Trastuzumab (440 mg).
It is a monoclonal antibody used mainly in HER2-positive breast cancer and some other cancers.

Mechanism 

• Some cancer cells have too much of a protein called HER2 on their surface, which makes them grow and divide faster.

• Trastuzumab (Neuzumab) attaches to the HER2 protein and blocks its activity.

• This slows or stops cancer cell growth and also helps the immune system destroy these cancer cells.

  Uses

  • HER2-positive breast cancer (early and advanced stages)

  • HER2-positive gastric (stomach) cancer

  • Used alone or with chemotherapy, depending on the stage of cancer.

    Adverse Effects 

    Common side effects:

    • Fever, chills (especially during first infusion)

    • Weakness, tiredness

    • Nausea, vomiting, diarrhea

    • Cough, shortness of breath

    • Skin rash